Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Oncotarget|August 26, 2015
Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genesJessamy C Tiffen, Dilini Gunatilake, Stuart J Gallagher, et al.
Genes, Chromosomes & Cancer|January 18, 2012
Identification of TFG (TRK-fused gene) as a putative metastatic melanoma tumor suppressor geneKen Dutton-Regester, Lauren G Aoude, Derek J Nancarrow, et al.
Nature Communications|December 3, 2014
Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanomaGeorgina V Long, Carina Fung, Alexander M Menzies, et al.
Pigment Cell & Melanoma Research|July 30, 2013
Melanomas of unknown primary have a mutation profile consistent with cutaneous sun-exposed melanomaKen Dutton-Regester, Hojabr Kakavand, Lauren G Aoude, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2014
BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impactHelen Rizos, Alexander M Menzies, Gulietta M Pupo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2017
PD-L1 Expression and Immune Escape in Melanoma Resistance to MAPK InhibitorsHojabr Kakavand, Robert V Rawson, Gulietta M Pupo, et al.
The Journal of Investigative Dermatology|August 31, 2012
BRAF mutation, NRAS mutation, and the absence of an immune-related expressed gene profile predict poor outcome in patients with stage III melanomaGraham J Mann, Gulietta M Pupo, Anna E Campain, et al.
Pathology|October 31, 2015
Tumour procurement, DNA extraction, coverage analysis and optimisation of mutation-detection algorithms for human melanoma genomesJames S Wilmott, Matthew A Field, Peter A Johansson, et al.
Journal of the National Cancer Institute|February 7, 2002
Dominant negative ATM mutations in breast cancer familiesGeorgia Chenevix-Trench, Amanda B Spurdle, Magtouf Gatei, et al.
Cancer Discovery|January 29, 2014
Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysisTiffany J Parmenter, Margarete Kleinschmidt, Kathryn M Kinross, et al.
Pageof 7